SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-018854
Filing Date
2022-10-27
Accepted
2022-10-27 16:23:13
Documents
1
Period of Report
2022-10-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4605
  Complete submission text file 0001567619-22-018854.txt   6039
Mailing Address 156 S. FIRST STREET ZIONSVILLE IN 46077
Business Address
Leonard Braden Michael (Reporting) CIK: 0001373603 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39438 | Film No.: 221337630

Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Issuer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations